The pharmaceutical and medical device industries operate in one of the most complex and highly regulated environments in the global economy. Rapid technological innovation, increasing regulatory scrutiny, pressure for cost containment, and growing expectations for patient safety and outcomes have fundamentally reshaped how organizations design strategies and make executive decisions. In parallel, digital transformation continues to redefine operational and clinical landscapes. Within this context, human capital has emerged as a critical driver of innovation, organizational resilience, and long-term competitiveness. Human Capital, Innovation, and Executive Decision-Making in Pharma and Medical Device Industries explores the intersection of human capital management, innovation processes, and executive decision-making in the pharmaceutical and medical device sectors. This book positions leadership, talent, organizational culture, and strategic governance as central elements shaping innovation performance and regulatory success. Integrating perspectives from management, engineering, healthcare, and organizational studies, it offers a comprehensive view of how executive decisions and human-centered strategies influence innovation outcomes in life sciences industries. Covering topics such as executive decision-making, regulated drug development, and workplace performance in healthcare, this book is a fundamental academic resource for graduate and doctoral students, medical device executives, R&D leaders, regulatory affairs professionals, healthcare innovation managers, and more.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Stéphanie Monteiro is a senior quality and regulatory affairs professional with extensive experience across the pharmaceutical, medical device, and medical technology sectors. Her professional background encompasses quality management systems, regulatory compliance, risk management, and product lifecycle governance in highly regulated healthcare environments, including pharma, MedTech, and medical device innovation contexts. She has built her career at the intersection of quality, innovation, and operational excellence, contributing to the development, validation, and continuous improvement of products and processes in accordance with international regulatory frameworks and standards. Her expertise includes quality assurance, compliance strategy, process optimization, and cross-functional collaboration with R&D, clinical, regulatory, and executive leadership teams. Stéphanie is actively involved in academic and applied research initiatives related to medical technology, healthcare innovation, and organizational performance, and has contributed to several academic publications and edited volumes in these domains. Her professional and academic interests focus on how quality systems, human capital, and leadership practices enable sustainable innovation and performance in regulated industries.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni
PAP. Etat : New. New Book. Shipped from UK. Established seller since 2000. N° de réf. du vendeur L2-9798337394114
Quantité disponible : Plus de 20 disponibles
Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-Unis
Paperback. Etat : new. Paperback. The pharmaceutical and medical device industries operate in one of the most complex and highly regulated environments in the global economy. Rapid technological innovation, increasing regulatory scrutiny, pressure for cost containment, and growing expectations for patient safety and outcomes have fundamentally reshaped how organizations design strategies and make executive decisions. In parallel, digital transformation continues to redefine operational and clinical landscapes. Within this context, human capital has emerged as a critical driver of innovation, organizational resilience, and long-term competitiveness. Human Capital, Innovation, and Executive Decision-Making in Pharma and Medical Device Industries explores the intersection of human capital management, innovation processes, and executive decision-making in the pharmaceutical and medical device sectors. This book positions leadership, talent, organizational culture, and strategic governance as central elements shaping innovation performance and regulatory success. Integrating perspectives from management, engineering, healthcare, and organizational studies, it offers a comprehensive view of how executive decisions and human-centered strategies influence innovation outcomes in life sciences industries. Covering topics such as executive decision-making, regulated drug development, and workplace performance in healthcare, this book is a fundamental academic resource for graduate and doctoral students, medical device executives, R&D leaders, regulatory affairs professionals, healthcare innovation managers, and more. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. N° de réf. du vendeur 9798337394114
Quantité disponible : 1 disponible(s)
Vendeur : CitiRetail, Stevenage, Royaume-Uni
Paperback. Etat : new. Paperback. The pharmaceutical and medical device industries operate in one of the most complex and highly regulated environments in the global economy. Rapid technological innovation, increasing regulatory scrutiny, pressure for cost containment, and growing expectations for patient safety and outcomes have fundamentally reshaped how organizations design strategies and make executive decisions. In parallel, digital transformation continues to redefine operational and clinical landscapes. Within this context, human capital has emerged as a critical driver of innovation, organizational resilience, and long-term competitiveness. Human Capital, Innovation, and Executive Decision-Making in Pharma and Medical Device Industries explores the intersection of human capital management, innovation processes, and executive decision-making in the pharmaceutical and medical device sectors. This book positions leadership, talent, organizational culture, and strategic governance as central elements shaping innovation performance and regulatory success. Integrating perspectives from management, engineering, healthcare, and organizational studies, it offers a comprehensive view of how executive decisions and human-centered strategies influence innovation outcomes in life sciences industries. Covering topics such as executive decision-making, regulated drug development, and workplace performance in healthcare, this book is a fundamental academic resource for graduate and doctoral students, medical device executives, R&D leaders, regulatory affairs professionals, healthcare innovation managers, and more. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. N° de réf. du vendeur 9798337394114
Quantité disponible : 1 disponible(s)
Vendeur : AussieBookSeller, Truganina, VIC, Australie
Paperback. Etat : new. Paperback. The pharmaceutical and medical device industries operate in one of the most complex and highly regulated environments in the global economy. Rapid technological innovation, increasing regulatory scrutiny, pressure for cost containment, and growing expectations for patient safety and outcomes have fundamentally reshaped how organizations design strategies and make executive decisions. In parallel, digital transformation continues to redefine operational and clinical landscapes. Within this context, human capital has emerged as a critical driver of innovation, organizational resilience, and long-term competitiveness. Human Capital, Innovation, and Executive Decision-Making in Pharma and Medical Device Industries explores the intersection of human capital management, innovation processes, and executive decision-making in the pharmaceutical and medical device sectors. This book positions leadership, talent, organizational culture, and strategic governance as central elements shaping innovation performance and regulatory success. Integrating perspectives from management, engineering, healthcare, and organizational studies, it offers a comprehensive view of how executive decisions and human-centered strategies influence innovation outcomes in life sciences industries. Covering topics such as executive decision-making, regulated drug development, and workplace performance in healthcare, this book is a fundamental academic resource for graduate and doctoral students, medical device executives, R&D leaders, regulatory affairs professionals, healthcare innovation managers, and more. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. N° de réf. du vendeur 9798337394114
Quantité disponible : 1 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Taschenbuch. Etat : Neu. Human Capital, Innovation, and Executive Decision-Making in Pharma and Medical Device Industries | Stéphanie Monteiro | Taschenbuch | Englisch | 2026 | IGI GLOBAL SCIENTIFIC PUBLISHING | EAN 9798337394114 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand. N° de réf. du vendeur 135708643
Quantité disponible : 5 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering. N° de réf. du vendeur 9798337394114
Quantité disponible : 2 disponible(s)